| Phase 4 |
| NCT04704999 |
Southeast Asia Dose Optimization of Tafenoquine |
Plasmodium Vivax Malaria |
Recruiting |
2026-10-09 |
| NCT07267559 |
Dual Orexin Antagonism and Emotion and Affective Processing Study |
Learning |
Recruiting |
2026-03-19 |
| NCT06068530 |
Mass Vaccine and Drug Administration, Bangladesh |
Plasmodium Falciparum Malaria |
Recruiting |
2025-12-18 |
| NCT06731374 |
Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15 |
Pneumococcal Disease |
Recruiting |
2025-04-15 |
| NCT07771595 |
Study of the Effects of Atomoxetine on Motivation |
Apathy |
Not Yet Recruiting |
2026-08-18 |
| NCT07194668 |
R21/MM Dosing, Presentations, and Preservatives |
Plasmodium Falciparum Malaria |
Not Yet Recruiting |
2026-08-04 |
| NCT05441267 |
A Study of Cardiovascular Events iN Diabetes Plus |
Diabetes Mellitus, Type 2 |
Active, Not Recruiting |
2026-06-23 |
| NCT03083197 |
Scrub Typhus Antibiotic Resistance Trial |
Scrub Typhus |
Active, Not Recruiting |
2026-04-28 |
| NCT00135226 |
ASCEND: A Study of Cardiovascular Events iN Diabetes |
Diabetes Mellitus |
Active, Not Recruiting |
2025-05-28 |
| Phase 3 |
| NCT06778564 |
Stratification and Treatment in Early Psychosis Study - ENHANCE |
Psychosis |
Recruiting |
2026-10-08 |
| NCT04381936 |
Randomised Evaluation of COVID-19 Therapy |
Pneumonia |
Recruiting |
2026-04-21 |
| NCT05951595 |
A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as… |
Uncomplicated Plasmodium Falciparum Malaria |
Recruiting |
2025-11-18 |
| NCT07093359 |
LINX vs Fundoplication |
Gastro-oesophageal Reflux Disease |
Recruiting |
2025-08-05 |
| NCT07326124 |
Stratification and Treatment in Early Psychosis Study -ASSIST |
Treatment Resistant Psychosis |
Not Yet Recruiting |
2026-10-08 |
| NCT07434973 |
Stratification and Treatment in Early Psychosis Study - PROMOTE |
Clinical High Risk for Psychosis (CHR) |
Not Yet Recruiting |
2026-10-08 |
| NCT03705234 |
A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People… |
Atherosclerotic Cardiovascular Disease |
Active, Not Recruiting |
2026-05-01 |
| NCT04704830 |
R21/Matrix-M in African Children Against Clinical Malaria |
Malaria |
Active, Not Recruiting |
2026-02-23 |
| NCT01252953 |
REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification |
Atherosclerotic Cardiovascular Disease |
Active, Not Recruiting |
2024-06-25 |
| Phase 2 |
| NCT07054931 |
Combination Vaccination and Broadly Neutralising Antibody Therapy in HIV |
HIV |
Recruiting |
2026-07-07 |
| NCT05648448 |
A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza |
Influenza |
Recruiting |
2026-04-14 |
| NCT05041907 |
Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early… |
COVID-19 |
Recruiting |
2026-02-19 |
| NCT06488300 |
Assessing Antiviral Treatments in Early Symptomatic RSV |
Respiratory Syncytial Virus |
Recruiting |
2025-07-02 |
| NCT07835321 |
Tafenoquine Drug Levels in Small Children |
Plasmodium Vivax Malaria |
Not Yet Recruiting |
2026-09-22 |
| NCT07074665 |
Dose Finding Trial of R21/Matrix-M in School Children |
Malaria (Plasmodium Falciparum) |
Active, Not Recruiting |
2026-08-24 |
| NCT05380388 |
A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults… |
Plasmodium Vivax Infection |
Not Yet Recruiting |
2026-03-24 |